Quick Answer
MARAVAI LIFESCIENCES HOLDINGS, INC. reported Operating Income Loss of -$215.27 million for the year ending 2025.
- MARAVAI LIFESCIENCES HOLDINGS, INC. showed an increase of +8.6% in Operating Income Loss from 2024 to 2025.
- This data is from MARAVAI LIFESCIENCES HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $34.82 million | Q2 2020: $8.12 million | Q3 2020: $45.72 million | Q1 2021: $91.19 million | Q2 2021: $153.54 million | Q3 2021: $155.38 million | Q1 2022: $167.37 million | Q2 2022: $180.70 million | Q3 2022: $116.90 million | Q1 2023: $2.53 million | Q2 2023: -$11.61 million | Q3 2023: -$15.42 million | Q1 2024: -$18.86 million | Q2 2024: -$13.44 million | Q3 2024: -$165.61 million | Q1 2025: -$49.16 million | Q2 2025: -$66.28 million | Q3 2025: -$41.03 million.
- Over the full 7 years of available data (2019 to 2025), MARAVAI LIFESCIENCES HOLDINGS, INC.'s Operating Income Loss has declined by 997.4%.
- Historical annual values: Fiscal year 2025: -$215.27 million | Fiscal year 2024: -$235.62 million | Fiscal year 2023: -$31.65 million | Fiscal year 2022: $574.22 million | Fiscal year 2021: $554.65 million | Fiscal year 2020: $119.90 million | Fiscal year 2019: $23.99 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: